Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial

Wulf, G. G., Altmann, B., Ziepert, M., D’Amore, F., Held, G., Greil, R., Tournilhac, O., Relander, T., Viardot, A., Wilhelm, M., Wilhelm, C., Pezzutto, A., Zijlstra, J. M., Neste, E. V. D., Lugtenburg, P. J., Doorduijn, J. K., Gelder, M. V., van Imhoff, G. W., Zettl, F., Braulke, F. & 9 others, Nickelsen, M., Glass, B., Rosenwald, A., Gaulard, P., Loeffler, M., Pfreundschuh, M., Schmitz, N., Trümper, L. & for the ACT-2 study investigators, Jan 2021, In: Leukemia. 35, 1, p. 143-155 13 p.

Research output: Contribution to journal › Article › Academic › peer-review

Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study

Kersten, M. J., Driessen, J., Zijlstra, J. M., Plattel, W. J., Morschhauser, F., Lugtenburg, P. J., Brice, P., Hutchings, M., Gastinne, T., Liu, R., Burggraaff, C. N., Nijland, M., Tonino, S. H., Arens, A. I. J., Valkema, R., van Tinteren, H., Lopez-Yurda, M., Diepstra, A., De Jong, D. & Hagenbeek, A., 1 Apr 2021, In: Haematologica. 106, 4, p. 1129-1137 9 p.

Research output: Contribution to journal › Article › Academic › peer-review

Cost-utility of an eHealth application ‘Oncokompas’ that supports cancer survivors in self-management: results of a randomised controlled trial

van der Hout, A., Jansen, F., van Uden-Kraan, C. F., Coupé, V. M., Holtmaat, K., Nieuwenhuijzen, G. A., Hardillo, J. A., de Jong, R. J. B., Tiren-Verbeet, N. L., Sommeijer, D. W., de Heer, K., Schaar, C. G., Sedee, R. J. E., Bosscha, K., van den Brekel, M. W. M., Petersen, J. F., Westerman, M., Honings, J., Takes, R. P., Houtenbos, I. & 9 others, van den Broek, W. T., de Bree, R., Jansen, P., Eerenstein, S. E. J., Leemans, C. R., Zijlstra, J. M., Cuijpers, P., van de Poll-Franse, L. V. & Verdonck-de Leeuw, I. M., Feb 2021, In: Journal of Cancer Survivorship. 15, 1, p. 77-86 10 p.

Research output: Contribution to journal › Article › Academic › peer-review

Interobserver agreement in automated metabolic tumor volume measurements of Deauville score 4 and 5 lesions at interim 18F-FDG PET in DLBCL

Zwezerijnen, G. J., Eertink, J. J., Burggraaff, C. N., Wiegers, S. E., Shaban, E. A., Pieplenbosch, S., Oprea-Lager, D. E., Lugtenburg, P. J., Hoekstra, O. S., de Vet, H. C., Zijlstra, J. M. & Boellaard, R., 5 Mar 2021, In: Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Research output: Contribution to journal › Article › Academic › peer-review

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial

Borchmann, P., Plütschow, A., Kobe, C., Greil, R., Meissner, J., Topp, M. S., Ostermann, H., Dierlamm, J., Mohm, J., Thiemer, J., Sökler, M., Kerkhoff, A., Ahlborn, M., Halbsguth, T. V., Martin, S., Keller, U., Balabanov, S., Pabst, T., Vogelhuber, M., Hüttmann, A. & 16 others, Wilhelm, M., Zijlstra, J. M., Moccia, A., Kuhnert, G., Bröckelmann, P. J., von Tresckow, B., Fuchs, M., Klimm, B., Rosenwald, A., Eich, H., Baues, C., Marnitz, S., Hallek, M., Diehl, V., Dietlein, M. & Engert, A., Feb 2021, In: The Lancet Oncology. 22, 2, p. 223-234 12 p.

Research output: Contribution to journal › Article › Academic › peer-review